Meiling Fu
Xiamen, 361101, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Corrigendum to 'Effective strategies to enhance the diagnosis and treatment of RCC: The application of biocompatible materials' [Mater. Today Bio 27 (2024) 101149].
Journal: Materials today. Bio
Published: August 30, 2024
NDR1 mediates PD-L1 deubiquitination to promote prostate cancer immune escape via USP10.
Journal: Cell communication and signaling : CCS
Published: June 12, 2024
Discovery of a small-molecule NDR1 agonist for prostate cancer therapy.
Journal: Frontiers in pharmacology
Published: January 08, 2024
Targeting the hedgehog pathway in MET mutation cancers and its effects on cells associated with cancer development.
Journal: Cell communication and signaling : CCS
Published: July 21, 2023
TOPK mediates immune evasion of renal cell carcinoma via upregulating the expression of PD-L1.
Journal: iScience
Published: March 26, 2023
Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma.
Journal: Frontiers in immunology
Published: February 22, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026